European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Mixed Fruits and Berries Improve Gut Microbiota and Attenuate Liver Alterations Induced by a Cafeteria Diet in Adolescent Rats February 2, 2026 NHSc’s HMO blend deemed effective for babies allergic to cow’s milk protein August 16, 2021 Effect of Prebiotic Yeast Mannan on Gut Health and Sleep Quality January 5, 2024
Mixed Fruits and Berries Improve Gut Microbiota and Attenuate Liver Alterations Induced by a Cafeteria Diet in Adolescent Rats February 2, 2026